$BICB CannaSens Delta9 The science behind the C
Post# of 98007
Posted On: 09/29/2015 11:45:10 AM
$BICB CannaSens Delta9
The science behind the CannaSens Delta9 THC detection device originates in part from the proprietary technology developed by BioCube's partner in this joint venture, IUT Medical GmbH, located in Berlin, Germany. IUT is a recognized applied science leader in the field of identification and detection methodologies, with a deep knowledge of technologies such as Ion Mobility Spectroscopy (IMS), Photo Ionization Detector (PID) analyzer and Gas Chromatographic Column (GC-Column). IUT-designed systems provide on-site detection and analysis of air particles for the presence of toxic chemical compounds, warfare agents, explosives and drugs. Through a combination of its state of the art R&D facility and manufacturing capabilities, IUT continues to enhance its knowledge of these complex and important technologies, while directly marketing and selling their detection systems to customers worldwide.
Utilizing sophisticated technology, BioCube and its strategic partner, IUT Medical, have developed CannaSens Delta9, a state-of-the-art portable THC breathalyzer device. Although some early research shows there may be potential benefits in the use of medical cannabis to treat various diseases and conditions, the Company is also keenly interested in promoting public safety and the responsible use of marijuana.
The science behind the CannaSens Delta9 THC detection device originates in part from the proprietary technology developed by BioCube's partner in this joint venture, IUT Medical GmbH, located in Berlin, Germany. IUT is a recognized applied science leader in the field of identification and detection methodologies, with a deep knowledge of technologies such as Ion Mobility Spectroscopy (IMS), Photo Ionization Detector (PID) analyzer and Gas Chromatographic Column (GC-Column). IUT-designed systems provide on-site detection and analysis of air particles for the presence of toxic chemical compounds, warfare agents, explosives and drugs. Through a combination of its state of the art R&D facility and manufacturing capabilities, IUT continues to enhance its knowledge of these complex and important technologies, while directly marketing and selling their detection systems to customers worldwide.
Utilizing sophisticated technology, BioCube and its strategic partner, IUT Medical, have developed CannaSens Delta9, a state-of-the-art portable THC breathalyzer device. Although some early research shows there may be potential benefits in the use of medical cannabis to treat various diseases and conditions, the Company is also keenly interested in promoting public safety and the responsible use of marijuana.
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼